- امروز : جمعه, ۱۵ فروردین , ۱۴۰۴
- برابر با : Friday - 4 April - 2025
اخبار ویژه
Silent Damage First: Alzheimer’s Disease Could Have Two Phases
Sports Concussion Outcomes Can Be Made Worse By Depression
Dad’s Use of Diabetes Med Metformin Won’t Raise Birth Defect Risk
Fitness, Activity Boosts Kids’ Mental Health, Too
Exercise in Pregnancy Might Lower Baby’s Odds for Asthma Later
Some IUDs May Raise The Odds for Breast Cancer, But Overall Risk Remains Low
Music Might Speed Your Recovery From Surgery
A Cancer Diagnosis Takes Devastating Toll on Family Finances
ویژه انگلیسی - Page 16 of 19
Silent Damage First: Alzheimer’s Disease Could Have Two Phases
Alzheimer’s disease might damage the brain in two distinct phases, a new study suggests.
Surgical Outcomes Better With More Women on Your Team
Heading for surgery? The ratio of women to men in the operating room could influence your recovery, new research shows.
Pedal Power: Biking Could Help Prevent Knee Arthritis
People who regularly ride bikes throughout their life are less likely to develop knee arthritis, a new study suggests.
Report Highlights Big Gaps in Cancer Outcomes Based on Race
U.S. cancer death rates are continuing to drop, falling by 33% between 1991 and 2020.
Tips to Celebrating Mom on Her Day, Even When Dementia Intervenes
Women account for two-thirds of all Americans living with Alzheimer’s disease, which means this Mother’s Day will be bittersweet for many families across the nation.
Oral Rinse Might Alert Doctors to Stomach Cancers
A quick swish at the doctor’s office could someday provide early detection of stomach cancer, the fourth-leading cause of cancer deaths worldwide, a new study reports.
Outdoor Workers Face Skin Cancer Danger
Steve Murray, 68, has spent a lot of time out in the sun, at work and at play.
Utah Kids Got E. Coli From Playing Around Lawn Sprinklers
Happily jumping around lawn sprinklers or playing with garden hoses on a hot summer day: An idyllic childhood scene.
One in 8 U.S. Adults Have Now Used Blockbuster Meds Like Ozempic
About 1 in 8 U.S. adults (12%) have tried a weight-loss drug like Wegovy, Ozempic, Zepbound or Mounjaro, a new KFF Health Tracking Poll says.
